Literature DB >> 28034471

Pentoxifylline - a review of its use in osteoradionecrosis.

A J Lyons1, P A Brennan2.   

Abstract

Pentoxifylline has been used to treat complications related to fibrosis for over 20 years. Formerly used to treat those after radiotherapy such as osteoradionecrosis (ORN), it is now being tried for medication-related osteonecrosis of the jaw (MRONJ), which can occur after prolonged use of bisphosphonates. We review theories on the formation of fibrosis in patients with ORN, discuss the pharmacology of pentoxifylline and vitamin E, and report published outcomes. To our knowledge no prospective randomised controlled trial has investigated the benefits of these agents in cases of ORN, but reported outcomes in many published case series are encouraging.
Copyright © 2016 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Pentoxifylline; head and neck; osteoradionecrosis; radiotherapy; review

Mesh:

Substances:

Year:  2016        PMID: 28034471     DOI: 10.1016/j.bjoms.2016.12.006

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  6 in total

Review 1.  Treatment of late sequelae after radiotherapy for head and neck cancer.

Authors:  Primož Strojan; Katherine A Hutcheson; Avraham Eisbruch; Jonathan J Beitler; Johannes A Langendijk; Anne W M Lee; June Corry; William M Mendenhall; Robert Smee; Alessandra Rinaldo; Alfio Ferlito
Journal:  Cancer Treat Rev       Date:  2017-07-18       Impact factor: 12.111

2.  Pentoxifylline and vitamin E reduce the severity of radiotherapy-induced oral mucositis and dysphagia in head and neck cancer patients: a randomized, controlled study.

Authors:  Rana Sayed; Lamia El Wakeel; Amr S Saad; Mohamed Kelany; Manal El-Hamamsy
Journal:  Med Oncol       Date:  2019-11-21       Impact factor: 3.064

Review 3.  Osteoradionecrosis of the Maxilla: Conservative Management and Reconstructive Considerations.

Authors:  Tom Shokri; Weitao Wang; Aurora Vincent; Jason E Cohn; Sameep Kadakia; Yadranko Ducic
Journal:  Semin Plast Surg       Date:  2020-05-06       Impact factor: 2.314

Review 4.  The Potential Therapeutic Role of Mesenchymal Stem Cells-Derived Exosomes in Osteoradionecrosis.

Authors:  Yuetian Li; Xinyue Wang; Yu Pang; Shuangcheng Wang; Meng Luo; Bo Huang
Journal:  J Oncol       Date:  2021-12-02       Impact factor: 4.375

5.  Osteoradionecrosis of the Hip, a Troublesome Complication of Radiation Therapy: Case Series and Systematic Review.

Authors:  Sheng-Hao Xu; Jin-Shuo Tang; Xian-Yue Shen; Zhi-Xin Niu; Jian-Lin Xiao
Journal:  Front Med (Lausanne)       Date:  2022-03-25

6.  The effects of pentoxifylline and tocopherol in jaw osteomyelitis.

Authors:  Mi Hyun Seo; Mi Young Eo; Hoon Myoung; Soung Min Kim; Jong Ho Lee
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2020-02-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.